唐氏综合征阿尔茨海默病谱系血液蛋白质组的纵向动态
研究纳入59名唐氏综合征成人,通过年度随访和OLINK技术检测血浆蛋白,发现CD14、CXCL17、EDA2R、GFAP、IGFBP2、NFL、SEPTIN3和SPON1随年龄纵向升高,而CBLN4降低;基线蛋白水平与未来认知下降相关。
要点
- 唐氏综合征成人中9种血浆蛋白呈现纵向变化轨迹。
- 基线蛋白水平可预测随时间的认知下降。
- 蛋白变化与认知子域变化的相关性未达显著。
核心结论
- 唐氏综合征中既往识别的血浆蛋白呈现不同纵向轨迹,基线水平与未来认知下降相关,提示这些蛋白可能参与阿尔茨海默病病理生理。
研究设计与样本
- 纵向队列研究,纳入59名唐氏综合征成人,中位年龄32岁,至少完成1次年度随访,使用OLINK技术检测血浆蛋白,贝叶斯建模分析轨迹。
主要发现
- CD14、CXCL17、EDA2R、GFAP、IGFBP2、NFL、SEPTIN3和SPON1随年龄纵向升高,CBLN4降低(所有后验分布≥99.12%)。
- 基线蛋白水平与认知下降相关,控制年龄后所有后验分布≥94.75%。
- 多重比较校正后,蛋白纵向变化与认知子域变化的相关性均不显著。
临床怎么用
- 这些血浆蛋白可能作为唐氏综合征阿尔茨海默病谱系的监测标志物,但尚需进一步验证。
局限性
- 样本量较小,仅59人,且仅14人完成第二次随访。
- 随访时间较短,中位第一次随访13.37个月。
- 认知子域分析中蛋白变化与认知变化的相关性未达显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Adults with Down syndrome (DS) have an increased risk of developing early Alzheimer disease. While our previous cross-sectional study investigated the blood proteome in the context of Alzheimer in DS, identifying CBLN4, CD14, C-X-C motif chemokine 17 (CXCL17), ectodysplasin A2 receptor (EDA2R), glial fibrillary acidic protein (GFAP), insulin-like growth factor binding protein-2 (IGFBP2), neurofilament light (NFL), SEPTIN3, and SPON1 as proteins of interest, longitudinal trajectories remain mostly unexplored. We aimed to characterize the longitudinal dynamics of these plasma proteins to evaluate their potential contribution to disease pathophysiology and associated cognitive decline. METHODS: Adults with diagnosis of DS and ability to understand instructions of neuropsychological assessments were recruited at Ludwig Maximilians University Hospital Munich, returning for at least 1 annual follow-up visit for repeated clinical assessment, neuropsychological testing, and blood sample collection after baseline visit. Longitudinal blood protein dynamics were assessed using OLINK technology. Bayesian modeling analyzed longitudinal protein trajectories and their impact on cognitive performance. Spearman correlations of regression-derived rates of change investigated relationships between proteins and cognitive subdomains stratified by clinical diagnosis. RESULTS: We included 59 adults with DS (46% female, median age = 32 years [interquartile range: 27-47]). All completed the first annual follow-up visit (median duration 13.37 months [12.35-20.95]), with 14 of them returning for a follow-up 2 visit (median 25.43 months [24.79-33.8]). Stratified analysis included 13 individuals with DS with (38% female, 54 years [49-58]) and 41 without diagnosis of cognitive decline (49% female, 29 years [24-35]). Cluster of differentiation 14, CXCL17, EDA2R, GFAP, IGFBP2, NFL, SEPTIN3, and SPON1 exhibited longitudinal increase, while CBLN4 decreased (all posterior distributions ≥ 99.12%), with age. Protein baseline levels were associated with cognitive decline over time while controlling for age in the whole cohort (all posterior distributions ≥ 94.75%). After correction for multiple comparisons, no longitudinal changes in protein markers exhibited a significant relationship when correlated with changes in cognitive subdomain performance within subcohorts. DISCUSSION: In DS, longitudinal characterization of all previously identified proteins revealed distinct trajectories over time and an association of baseline levels with future cognitive decline. This suggests potential contributions of these proteins to the complex underlying pathophysiology of Alzheimer in DS and should motivate further investigation.
引用
- Wagemann O, Nuebling GS, Sandkühler K, et al. Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome. Neurology. 2026. PMID: 42679336. doi:10.1212/WNL.0000000000218494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。